| Literature DB >> 24816581 |
Hien K Duong1, Bipin N Savani2, Ed Copelan3, Steven Devine4, Luciano J Costa5, John R Wingard6, Paul Shaughnessy7, Navneet Majhail8, Miguel-Angel Perales9, Corey S Cutler10, William Bensinger11, Mark R Litzow12, Mohamad Mohty13, Richard E Champlin14, Helen Leather6, Sergio Giralt9, Paul A Carpenter11.
Abstract
Peripheral blood progenitor cell mobilization practices vary significantly among institutions. Effective mobilization regimens include growth factor alone, chemotherapy and growth factor combined, and, more recently, incorporation of plerixafor with either approach. Many institutions have developed algorithms to improve stem cell mobilization success rates and cost-effectiveness. However, an optimal stem cell mobilization regimen has not been defined. Practical guidelines are needed to address important clinical questions, including which growth factor is optimal, what chemotherapy and dose is most effective, and when to initiate leukapheresis. We present recommendations, based on a comprehensive review of the literature, from the American Society of Blood and Marrow Transplantation.Entities:
Keywords: Hematopoietic transplantation; Peripheral blood; Progenitor cell mobilization
Mesh:
Year: 2014 PMID: 24816581 DOI: 10.1016/j.bbmt.2014.05.003
Source DB: PubMed Journal: Biol Blood Marrow Transplant ISSN: 1083-8791 Impact factor: 5.742